AIMD Ainos Inc Cumulative Company Assets

Official company branding of Ainos Corp (AIMD)

Ainos, Inc. (AIMD) specializes in rapid diagnostics via AI-powered breath analysis. Historical price action confirms confidence in the accuracy of such biomarkers, with the current metric standing at 21.74. The business remains resilient to market volatility, leveraging the success of clinical trials and the launch of new products. Furthermore, the company's portable solutions support environmental sustainability by reducing trips to medical centers and decreasing the volume of hospital waste.

Company Total Assets: Ainos Inc (AIMD) for 04/28/2023 - 10/30/2026

Analytical breakdowns and data insights for company Ainos Corp (AIMD)

- stock quotes and analyst forecast:
Share Price ainos.com|AIMD - Price Target Chart
- market capitalization data:
Market Valuation Ainos Corporation|AIMD - Enterprise Value
- company book value details:
Net Asset Value per Share Ainos|AIMD - Book Capitalization|Capitalization to Book Value Ratio ainos.com|AIMD - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Ainos, Inc.|AIMD - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Ainos Corporation|AIMD - Company Aggregate Debts|Debts to Book Capitalization Ainos Corporation|AIMD - Company Long-Term Debt|Company Short-Term Debt Ainos|Immediate Liquidity ainos.com
- company profitability and valuation multiples indicators:
AIMD - Company Net Income
Fundamental valuation:Ainos, Inc.
Manufactured product of ainos.com

The scaling of the VEMS platform and the accuracy of organic compound recognition depend directly on resource provision, which reflects the aggregate assets and liabilities of Ainos, Inc. (AIMD). This metric, reconstructed through return on assets (ROA), allows investors to assess capital management efficiency, while analyzing the company's financial asset volume helps identify overpayment risks at peak values or the threat of a deep drawdown in a timely manner.

Main competitors

Total Business Assets A|Aggregate Company Assets Quest Diagnostics Incorporated|Cumulative Company Assets Illumina Inc (ILMN)|Company Total Assets EXAS|RVTY - Company Assets|Company Total Assets BIO (Bio-Rad Laboratories)|NNNN: Total Business Assets|Sotera Health - Company Total Assets|QDEL - Company Total Assets|OPKO Corp (OPK) - Aggregate Company Assets|Total Business Assets CDNA|MRVI (Maravai LifeSciences) - Company Total Assets|Company Total Assets fulgentgenetics.com|Aggregate Company Assets Standard BioTools (LAB)|Aggregate Company Assets CTKB (Cytek Biosciences Inc)|OraSure Technologies Inc - Cumulative Company Assets|Exagen Inc (XGN) - Company Assets|MDXH - Aggregate Company Assets|Company Total Asset Base luciddx.com LUCD|PRE: Company Total Assets|IMDX - Company Total Asset Base|Aggregate Company Assets Trinity Biotech PLC|ProPhase Labs Corp (PRPH) - Company Total Asset Base|Company Total Assets CODX|Company Total Assets heartsciences.com (HSCS)|Company Total Assets BMRA (Biomerica)|Company Total Asset Base Cardio Diagnostics Holdings Inc. (CDIO)|VRAX - Aggregate Company Assets|BJDX (Bluejay Diagnostics Corp) - Total Business Assets|Aspira Women's Health (AWH) - Aggregate Company Assets|Company Assets acceleratediagnostics.com (AXDX)|Aggregate Company Assets CENTOGENE N.V.|Enzo (ENZ) - Company Total Asset Base|Cumulative Company Assets FRES (Fresh2 Group Limited)|GENE (gtglabs.com) - Aggregate Asset Value|Company Total Assets ME (23andMe Holding Co.)|Company Total Asset Base psychemedics.com (PMD)